ORGO Organogenesis Holdings Inc

Price (delayed)

$16.51

Market cap

$2.12B

P/E Ratio

40.27

Dividend/share

N/A

EPS

$0.41

Enterprise value

$2.14B

Highlights
The EPS has surged by 195% year-on-year and by 141% since the previous quarter
The net income has soared by 146% from the previous quarter
The quick ratio has grown by 39% year-on-year but it has declined by 2.4% since the previous quarter
ORGO's debt is up by 17% since the previous quarter but it is down by 10% year-on-year

Key stats

What are the main financial stats of ORGO
Market
Shares outstanding
128.22M
Market cap
$2.12B
Enterprise value
$2.14B
Valuations
Price to earnings (P/E)
40.27
Price to book (P/B)
13.43
Price to sales (P/S)
5.57
EV/EBIT
38.09
EV/EBITDA
32.76
EV/Sales
5.64
Earnings
Revenue
$379.12M
EBIT
$56.14M
EBITDA
$65.27M
Free cash flow
$746,000
Per share
EPS
$0.41
Free cash flow per share
$0.01
Book value per share
$1.23
Revenue per share
$2.96
TBVPS
$2.04
Balance sheet
Total assets
$319.18M
Total liabilities
$161.89M
Debt
$99.17M
Equity
$157.29M
Working capital
$111.23M
Liquidity
Debt to equity
0.63
Current ratio
2.5
Quick ratio
2.03
Net debt/EBITDA
0.33
Margins
EBITDA margin
17.2%
Gross margin
75.2%
Net margin
11.7%
Operating margin
14.6%
Efficiency
Return on assets
16.4%
Return on equity
43.7%
Return on invested capital
29.8%
Return on capital employed
22.9%
Return on sales
14.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ORGO stock price

How has the Organogenesis Holdings stock price performed over time
Intraday
-1.43%
1 week
9.19%
1 month
-0.9%
1 year
332.2%
YTD
119.26%
QTD
-9.39%

Financial performance

How have Organogenesis Holdings's revenue and profit performed over time
Revenue
$379.12M
Gross profit
$285.1M
Operating income
$55.19M
Net income
$44.21M
Gross margin
75.2%
Net margin
11.7%
ORGO's net margin has soared by 175% year-on-year and by 121% since the previous quarter
The net income has soared by 146% from the previous quarter
Organogenesis Holdings's operating income has soared by 101% from the previous quarter
Organogenesis Holdings's operating margin has surged by 80% QoQ

Growth

What is Organogenesis Holdings's growth rate over time

Valuation

What is Organogenesis Holdings stock price valuation
P/E
40.27
P/B
13.43
P/S
5.57
EV/EBIT
38.09
EV/EBITDA
32.76
EV/Sales
5.64
The EPS has surged by 195% year-on-year and by 141% since the previous quarter
The P/B is 66% below the 5-year quarterly average of 39.1 but 41% above the last 4 quarters average of 9.5
ORGO's equity is up by 8% QoQ
ORGO's P/S is 142% above its 5-year quarterly average of 2.3 and 99% above its last 4 quarters average of 2.8
The company's revenue rose by 43% YoY and by 12% QoQ

Efficiency

How efficient is Organogenesis Holdings business performance
The ROA has soared by 176% YoY and by 122% from the previous quarter
Organogenesis Holdings's return on equity has surged by 135% YoY and by 75% QoQ
The return on invested capital has surged by 80% since the previous quarter
The return on sales has surged by 68% since the previous quarter

Dividends

What is ORGO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ORGO.

Financial health

How did Organogenesis Holdings financials performed over time
ORGO's total assets is 97% greater than its total liabilities
ORGO's total assets has surged by 53% year-on-year and by 8% since the previous quarter
The quick ratio has grown by 39% year-on-year but it has declined by 2.4% since the previous quarter
ORGO's debt is 37% smaller than its equity
The debt to equity has dropped by 77% year-on-year but it is up by 9% since the previous quarter
ORGO's debt is up by 17% since the previous quarter but it is down by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.